IN2014CN00572A - - Google Patents

Info

Publication number: IN2014CN00572A
Authority: IN; India
Prior art keywords: compounds; infections; salts; treating; formula
Prior art date: 2011-08-19

Application number

Other languages

English (en)

Inventor

Pek Yoke Chong

John F Miller

Andrew James Peat

John Brad Shotwell

Original Assignee

Glaxo Group Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2011-08-19

Filing date

2012-08-10

Publication date

2015-04-03

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47746761&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN2014CN00572(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2012-08-10 Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd

2015-04-03 Publication of IN2014CN00572A publication Critical patent/IN2014CN00572A/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/025—Boronic and borinic acid compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/69—Boron compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D307/84—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D307/85—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/027—Organoboranes and organoborohydrides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/04—Esters of boric acids

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Virology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Gastroenterology & Hepatology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Molecular Biology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Plural Heterocyclic Compounds (AREA)

IN572CHN2014 2011-08-19 2012-08-10 IN2014CN00572A (fr)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US201161525440P	2011-08-19	2011-08-19
US201261650681P	2012-05-23	2012-05-23
PCT/US2012/050268 WO2013028371A1 (fr)	2011-08-19	2012-08-10	Composés benzofuranes pour le traitement d'infections par le virus de l'hépatite c

Publications (1)

Publication Number	Publication Date
IN2014CN00572A true IN2014CN00572A (fr)	2015-04-03

Family

ID=47746761

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IN572CHN2014 IN2014CN00572A (fr)	2011-08-19	2012-08-10

Country Status (38)

Country	Link
US (2)	US8927593B2 (fr)
EP (2)	EP3199531A1 (fr)
JP (2)	JP6367712B2 (fr)
KR (1)	KR101913800B1 (fr)
CN (1)	CN103732065B (fr)
AR (1)	AR087563A1 (fr)
AU (1)	AU2012299295B2 (fr)
BR (1)	BR112014002845A2 (fr)
CA (1)	CA2844086A1 (fr)
CL (2)	CL2014000393A1 (fr)
CO (1)	CO6862153A2 (fr)
CR (1)	CR20140078A (fr)
CY (1)	CY1118399T1 (fr)
DK (1)	DK2744332T3 (fr)
DO (1)	DOP2014000034A (fr)
EA (1)	EA032841B1 (fr)
ES (1)	ES2611731T3 (fr)
HR (1)	HRP20161743T1 (fr)
HU (1)	HUE030300T2 (fr)
IL (1)	IL230487B (fr)
IN (1)	IN2014CN00572A (fr)
JO (1)	JO3281B1 (fr)
LT (1)	LT2744332T (fr)
MA (1)	MA35443B1 (fr)
ME (1)	ME02588B (fr)
MX (1)	MX354676B (fr)
PE (1)	PE20141201A1 (fr)
PH (1)	PH12014500385A1 (fr)
PL (1)	PL2744332T3 (fr)
PT (1)	PT2744332T (fr)
RS (1)	RS55462B1 (fr)
SG (1)	SG10201606883QA (fr)
SI (1)	SI2744332T1 (fr)
SM (2)	SMT201700028T1 (fr)
TW (1)	TWI538915B (fr)
UY (1)	UY34274A (fr)
WO (1)	WO2013028371A1 (fr)
ZA (1)	ZA201401020B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SG10201606646RA (en) *	2011-08-17	2016-09-29	Glaxosmithkline Llc	Therapeutic methods
IN2014CN00572A (fr)	2011-08-19	2015-04-03	Glaxo Group Ltd
EP3218485A1 (fr) *	2014-11-10	2017-09-20	Glaxosmithkline Intellectual Property (No. 2) Limited	Compositions pharmaceutiques à action prolongée contre l'hépatite c
SG11201703646SA (en) *	2014-11-10	2017-06-29	Glaxosmithkline Intellectual Property (No 2) Ltd	Combination long acting compositions and methods for hepatitis c
KR20180006522A (ko)	2016-07-07	2018-01-18	삼성디스플레이 주식회사	액정 조성물 및 이를 포함하는 액정 표시 장치
WO2018026656A1 (fr) *	2016-08-01	2018-02-08	University Of Pittsburgh -Of The Commonwealth System Of Higher Education	Carbonates d'éthers de boryle, et acétals cycliques utilisés comme véhicules d'administration de médicaments déclenchés par oxydation
AU2018227811A1 (en) *	2017-03-02	2019-09-19	Assembly Biosciences, Inc.	Cyclic sulfamide compounds and methods of using same
IL276013B2 (en) *	2018-01-17	2024-03-01	Glaxosmithkline Ip Dev Ltd	Pi4kiiibeta inhibitors
WO2021079984A1 (fr) *	2019-10-25	2021-04-29	大日本住友製薬株式会社	Nouveau composé cyclique condensé substitué
CN111026203B (zh) *	2019-12-02	2021-01-26	宁波德晶元科技有限公司	一种适用于真空热水壶的加热控制方法与系统
JP2023554665A (ja) *	2020-12-18	2023-12-28	ベーリンガーインゲルハイムアニマルヘルスユーエスエイインコーポレイテッド	ホウ素含有ピラゾール化合物、それらを含む組成物、それらの方法及び使用

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6083903A (en)	1994-10-28	2000-07-04	Leukosite, Inc.	Boronic ester and acid compounds, synthesis and uses
WO2001002601A2 (fr) *	1999-07-07	2001-01-11	Du Pont Pharmaceuticals Company	Systemes de dosage cellulaire destines a l'examen de l'activite de la protease ns3 hcv
PT3078667T (pt)	2001-01-25	2018-12-28	The United States Of America Represented By The Sec Dep Of Health And Human Services	Formulação de compostos de ácido borónico
UA79834C2 (en) *	2002-11-01	2007-07-25	Viropharma Inc	Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases
BRPI0619132A2 (pt) *	2005-12-01	2011-09-13	Wyeth Corp	composto métodos para inibir a replicação de um vìrus de hepatite c, para tratar ou prevenir uma infecção viral de hepatite c em um mamìfero e para inibir rna polimerase dependente do rna de hepatite c, e, composição farmacêutica
NZ570257A (en)	2006-02-16	2011-11-25	Anacor Pharmaceuticals Inc	Boron-containing small molecules as anti-inflammatory agents
CA2651212A1 (fr) *	2006-05-02	2007-11-15	Anacor Pharmaceuticals, Inc.	Substances therapeutiques contenant du bore resistant a l'hydrolyse et methodes d'utilisation
US20070286822A1 (en)	2006-06-12	2007-12-13	Anacor Pharmaceuticals Inc.	Compounds for the Treatment of Periodontal Disease
CA2963784A1 (fr) *	2007-06-08	2008-12-18	Mannkind Corporation	Inhibiteurs d'ire-1.alpha
GB0719366D0 (en) *	2007-10-03	2007-11-14	Smithkline Beecham Corp	Compounds
WO2009111676A2 (fr)	2008-03-06	2009-09-11	Anacor Pharmaceuticals, Inc	Petites molécules contenant du bore utilisées en tant qu'agents anti-inflammatoires
JP2011512341A (ja)	2008-02-14	2011-04-21	エフ．ホフマン−ラロシュアーゲー	抗ウイルス性複素環化合物
WO2009137500A1 (fr)	2008-05-05	2009-11-12	Wyeth	Composés de benzofurane substitués en 6 pour traiter l’infection par le virus de l’hépatite c
WO2009137493A1 (fr)	2008-05-05	2009-11-12	Wyeth	Composés benzofurane substitués en position 2 pour traiter une infection par le virus de l'hépatite c
TW201008933A (en)	2008-08-29	2010-03-01	Hutchison Medipharma Entpr Ltd	Pyrimidine compounds
EP2348863A4 (fr)	2008-09-04	2012-03-07	Anacor Pharmaceuticals Inc	Petites molécules contenant du bore
WO2011050284A1 (fr) *	2009-10-23	2011-04-28	Glaxosmithkline Llc	Agents antiviraux de pyrazolylpyridine
TW201138786A (en)	2010-02-19	2011-11-16	Glaxo Group Ltd	Therapeutic compounds
WO2011106929A1 (fr)	2010-03-02	2011-09-09	Merck Sharp & Dohme Corp.	Inhibiteurs de polymérase du virus de l'hépatite c ns5b
AR080433A1 (es)	2010-03-02	2012-04-11	Merck Sharp & Dohme	Derivados de benzofurancarboxamidas utiles para tratar o prevenir infecciones por vhc y composiciones farmaceuticas que los contienen.
WO2012067663A1 (fr)	2010-11-18	2012-05-24	Glaxo Group Limited	Composés
WO2012067664A1 (fr)	2010-11-18	2012-05-24	Glaxo Group Limited	Composés
SG10201606646RA (en) *	2011-08-17	2016-09-29	Glaxosmithkline Llc	Therapeutic methods
WO2013025975A1 (fr) *	2011-08-17	2013-02-21	Glaxosmithkline Llc	Traitements combinés pour l'hépatite c
IN2014CN00572A (fr)	2011-08-19	2015-04-03	Glaxo Group Ltd

2012
- 2012-08-10 IN IN572CHN2014 patent/IN2014CN00572A/en unknown
- 2012-08-10 HR HRP20161743TT patent/HRP20161743T1/hr unknown
- 2012-08-10 CA CA2844086A patent/CA2844086A1/fr not_active Abandoned
- 2012-08-10 KR KR1020147007196A patent/KR101913800B1/ko not_active Expired - Fee Related
- 2012-08-10 ES ES12826498.3T patent/ES2611731T3/es active Active
- 2012-08-10 PT PT128264983T patent/PT2744332T/pt unknown
- 2012-08-10 AU AU2012299295A patent/AU2012299295B2/en not_active Ceased
- 2012-08-10 SG SG10201606883QA patent/SG10201606883QA/en unknown
- 2012-08-10 CN CN201280040219.3A patent/CN103732065B/zh not_active Expired - Fee Related
- 2012-08-10 SI SI201230826A patent/SI2744332T1/sl unknown
- 2012-08-10 US US13/885,500 patent/US8927593B2/en not_active Expired - Fee Related
- 2012-08-10 JP JP2014526090A patent/JP6367712B2/ja not_active Expired - Fee Related
- 2012-08-10 SM SM20170028T patent/SMT201700028T1/it unknown
- 2012-08-10 LT LTEP12826498.3T patent/LT2744332T/lt unknown
- 2012-08-10 ME MEP-2016-287A patent/ME02588B/fr unknown
- 2012-08-10 EA EA201490213A patent/EA032841B1/ru not_active IP Right Cessation
- 2012-08-10 RS RS20161131A patent/RS55462B1/sr unknown
- 2012-08-10 PH PH1/2014/500385A patent/PH12014500385A1/en unknown
- 2012-08-10 PE PE2014000197A patent/PE20141201A1/es not_active Application Discontinuation
- 2012-08-10 EP EP16195408.6A patent/EP3199531A1/fr not_active Withdrawn
- 2012-08-10 BR BR112014002845A patent/BR112014002845A2/pt not_active Application Discontinuation
- 2012-08-10 PL PL12826498T patent/PL2744332T3/pl unknown
- 2012-08-10 DK DK12826498.3T patent/DK2744332T3/en active
- 2012-08-10 HU HUE12826498A patent/HUE030300T2/en unknown
- 2012-08-10 MX MX2014001989A patent/MX354676B/es active IP Right Grant
- 2012-08-10 EP EP12826498.3A patent/EP2744332B1/fr active Active
- 2012-08-10 WO PCT/US2012/050268 patent/WO2013028371A1/fr not_active Ceased
- 2012-08-16 JO JOP/2012/0233A patent/JO3281B1/ar active
- 2012-08-16 AR ARP120103008A patent/AR087563A1/es unknown
- 2012-08-17 TW TW101130017A patent/TWI538915B/zh not_active IP Right Cessation
- 2012-08-17 UY UY0001034274A patent/UY34274A/es not_active Application Discontinuation
2014
- 2014-01-16 IL IL230487A patent/IL230487B/en not_active IP Right Cessation
- 2014-01-23 CO CO14013113A patent/CO6862153A2/es active IP Right Grant
- 2014-02-10 ZA ZA201401020A patent/ZA201401020B/en unknown
- 2014-02-17 CL CL2014000393A patent/CL2014000393A1/es unknown
- 2014-02-18 CR CR20140078A patent/CR20140078A/es unknown
- 2014-02-19 DO DO2014000034A patent/DOP2014000034A/es unknown
- 2014-03-13 MA MA36832A patent/MA35443B1/fr unknown
- 2014-11-20 US US14/548,524 patent/US9682999B2/en not_active Expired - Fee Related
2016
- 2016-12-22 JP JP2016249387A patent/JP2017125010A/ja active Pending
- 2016-12-27 CY CY20161101345T patent/CY1118399T1/el unknown
2017
- 2017-01-18 SM SM201700028T patent/SMT201700028B/it unknown
- 2017-02-03 CL CL2017000293A patent/CL2017000293A1/es unknown

Also Published As

Publication number	Publication date
UY34274A (es)	2013-04-05
SMT201700028T1 (it)	2017-03-08
BR112014002845A2 (pt)	2017-02-21
SMT201700028B (it)	2017-03-08
HUE030300T2 (en)	2017-04-28
EP2744332A4 (fr)	2015-01-14
US20130237501A1 (en)	2013-09-12
DK2744332T3 (en)	2017-01-16
EP3199531A1 (fr)	2017-08-02
PL2744332T3 (pl)	2017-03-31
JO3281B1 (ar)	2018-09-16
ZA201401020B (en)	2020-11-25
ES2611731T3 (es)	2017-05-10
CN103732065A (zh)	2014-04-16
TW201321390A (zh)	2013-06-01
IL230487B (en)	2019-06-30
US8927593B2 (en)	2015-01-06
LT2744332T (lt)	2017-01-10
HRP20161743T1 (hr)	2017-02-24
TWI538915B (zh)	2016-06-21
WO2013028371A1 (fr)	2013-02-28
PE20141201A1 (es)	2014-10-03
AU2012299295A1 (en)	2014-02-20
KR20140054287A (ko)	2014-05-08
US9682999B2 (en)	2017-06-20
JP2017125010A (ja)	2017-07-20
MX2014001989A (es)	2014-02-27
CL2014000393A1 (es)	2014-08-01
CL2017000293A1 (es)	2017-10-06
CA2844086A1 (fr)	2013-02-28
EA201490213A1 (ru)	2014-07-30
MX354676B (es)	2018-03-15
AU2012299295B2 (en)	2016-03-31
CO6862153A2 (es)	2014-02-10
SG10201606883QA (en)	2016-10-28
EA032841B1 (ru)	2019-07-31
KR101913800B1 (ko)	2018-11-01
IL230487A0 (en)	2014-03-31
DOP2014000034A (es)	2014-06-01
JP2014527529A (ja)	2014-10-16
CY1118399T1 (el)	2017-06-28
MA35443B1 (fr)	2014-09-01
EP2744332B1 (fr)	2016-10-26
PT2744332T (pt)	2017-01-24
US20150080343A1 (en)	2015-03-19
PH12014500385A1 (en)	2020-06-22
ME02588B (fr)	2017-06-20
RS55462B1 (sr)	2017-04-28
CR20140078A (es)	2014-03-20
CN103732065B (zh)	2016-10-26
EP2744332A1 (fr)	2014-06-25
JP6367712B2 (ja)	2018-08-01
AR087563A1 (es)	2014-04-03
SI2744332T1 (sl)	2017-01-31

Publication	Publication Date	Title
MY170941A (en)	2019-09-19	Pyrimidine derivatives for the treatment of viral infections
IN2014MN02652A (fr)	2015-08-21
IN2014MN02658A (fr)	2015-08-21
IN2014MN02657A (fr)	2015-08-28
IN2015MN00478A (fr)	2015-09-04
IN2015DN01156A (fr)	2015-06-26
IN2014MN00862A (fr)	2015-04-17
MX375789B (es)	2025-03-07	Sulfamoilarilamidas y su uso como medicamentos para el tratamiento de hepatitis b.
PH12014500385A1 (en)	2020-06-22	Benzofuran compounds for the treatment of hepatitis c virus infections
PH12015500724B1 (en)	2015-06-01	1, 2, 4-triazine derivatives for the treatment of viral infections
MX2015011193A (es)	2015-11-13	Compuestos antivirales.
WO2011160024A3 (fr)	2013-07-18	Composés utiles en tant qu'agents antiviraux, compositions, et procédés d'utilisation
WO2013106689A8 (fr)	2014-06-05	Inhibiteurs de la protéase ns3 du vhc
PH12014502551A1 (en)	2015-01-21	Oligonucleotide chelate complex-polypeptide compositions and methods
BR112014015582A2 (pt)	2017-06-13	compostos antivirais
MX2015011198A (es)	2015-11-30	Compuestos antivirales.
MX2015010790A (es)	2015-11-26	Derivados de anilina sustituidos con n-heteroarilo como antivirales de vhc.
IN2015DN02109A (fr)	2015-08-14
PH12017500817A1 (en)	2017-10-02	Long acting pharmaceutical compositions for hepatitis c
MX2015010892A (es)	2015-12-03	Compuestos antivirales.
MX2015011125A (es)	2015-11-11	Compuestos antivirales.
MX2015011126A (es)	2015-11-11	Compuestos antivirales.
CU20140133A7 (es)	2015-03-30	Composiciones y métodos de polipéptidos-complejo de quelato de oligonucleótido
UA113722C2 (uk)	2017-03-10	Фармацевтична композиція